Feedback / Questions
solengepras (CVN424) - Cerevance
https://www.globenewswire.com/news-release/2025/12/06/3201025/0/en/Cerevance-Showcases-Positive-Phase-2-Results-Demonstrating-Significant-Reduction-in-OFF-Time-with-Solengepras-as-an-Adjunctive-Treatment-in-Parkinson-s-Disease.html
Dec 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next